Kent Crews, MD
Ophthalmology · Fort Collins, CONPI 1831195288
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,000 of the $2,872 with a category attached, or 69.6%. Alcon accounts for 71.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $2,204 and has fallen 95.6% since, to $96 in 2025.
Across 30 payments — averaging $95.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Regeneron Healthcare Solutions, Inc.$228
- Genentech, Inc.$160
- Dutch Ophthalmic, USA$123
- AbbVie$77
- Rxsight Inc$50
- plus $185 from 7 others
Across 82 payments — averaging $6084.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$499K
What the payments were for
- Speaking & faculty fees$2,00070%
- Food & beverage$87230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 4 | $2,051 |
| Regeneron Healthcare Solutions, Inc. | 3 | $228 |
| Genentech, Inc. | 8 | $160 |
| Dutch Ophthalmic, USA | 1 | $123 |
| AbbVie(2 entities) | 4 | $77 |
| Rxsight Inc | 1 | $50 |
| Genentech USA, Inc. | 2 | $47 |
| Carl Zeiss Meditec USA, Inc. | 2 | $39 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $27 |
| Novartis | 1 | $21 |
| Biogen | 1 | $20 |
| Sandoz | 1 | $18 |
| Rayner Intraocular Lenses Limited | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Air Optix Color$2,000
- DAILIES TOTAL1$2,000
- Precision 1$2,000
- EVA Ophthalmic Surgical System$123
- EYLEA$116
How this compares
$2,872 in reported general payments places this provider in the 70th percentile of 262 ophthalmology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 65 | $2,401 |
| Latanoprost | 51 | $760 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 20 | $336 |
| Brimonidine Tartrate | 18 | $277 |
| Ketorolac Tromethamine | 11 | $257 |
| Timolol Maleate | 20 | $191 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Fort Collins
- Gary FosterFort Collins$75K
- Jason MayerFort Collins$42K
- Karl OlsenFort Collins$15K
- Brittney StatlerFort Collins$8K
- Matthew AsanoFort Collins$4K
- Mark PackerBoulder$3.5M
- Jon DishlerGreenwood Village$1M
- Mark DaceyDenver$370K
- Cristos IfantidesDenver$343K
- Geeta Lalchandani LalwaniBoulder$319K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.